Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation

Epithelial ovarian cancer (EOC) is a highly heterogeneous disease encompassing several distinct molecular subtypes and clinical entities. Despite the initial success of surgical debulking and adjuvant chemotherapy, recurrence with chemotherapy resistant tumors is common in patients with EOC and lead...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jianbo, Liao, Qianjin, Price, Matthew, Moriarity, Branden, Wolf, Natalie, Felices, Martin, Miller, Jeffrey S., Geller, Melissa A., Bendzick, Laura, Hopps, Rachel, Starr, Timothy K., O'Connor, Christine H., Tarullo, Sarah, Nelson, Andrew C., Turley, Eva, Wang, Jing, McCarthy, James B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695353/
https://www.ncbi.nlm.nih.gov/pubmed/34942534
http://dx.doi.org/10.1016/j.tranon.2021.101318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695353/
https://www.ncbi.nlm.nih.gov/pubmed/34942534
http://dx.doi.org/10.1016/j.tranon.2021.101318

Ejemplares similares